Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
2008
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
L01AA09
|
| gptkbp:CASNumber |
16506-27-7
|
| gptkbp:chemicalFormula |
C16H21Cl2N3O2
|
| gptkbp:drugClass |
nitrogen mustard derivative
|
| gptkbp:genericName |
gptkb:bendamustine
|
| https://www.w3.org/2000/01/rdf-schema#label |
Treanda
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Teva_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
antineoplastic agent
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
fever
nausea vomiting diarrhea anorexia fatigue rash myelosuppression |
| gptkbp:synonym |
bendamustine hydrochloride
|
| gptkbp:usedFor |
chronic lymphocytic leukemia
indolent B-cell non-Hodgkin lymphoma |
| gptkbp:bfsParent |
gptkb:bendamustine
|
| gptkbp:bfsLayer |
8
|